Menu Search
Equities

111 Inc

YI:NMQ

111 Inc

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)1.19
  • Today's Change0.06 / 5.31%
  • Shares traded17.71k
  • 1 Year change-62.54%
  • Beta0.4765
Data delayed at least 15 minutes, as of Jul 26 2024 20:58 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

111, Inc. is a China-based Internet medical and health company. The Company is mainly engaged in the provision of online medical services, drug purchasing and health management services through Internet and information technology. The Company mainly conducts its business in the domestic market.

  • Revenue in USD (TTM)2.04bn
  • Net income in USD-51.68m
  • Incorporated--
  • Employees1.52k
  • Location
    111 Inc3-4/FNo.295 Zuchongzhi Road, Pudong New AreaSHANGHAI 201203ChinaCHN
  • Phone+86 2 120536666
  • Websitehttp://gangling.111.com.cn/
More ▼

Institutional shareholders

3.89%Per cent of shares held by top holders
HolderShares% Held
JPMorgan Securities LLC (Investment Management)as of 31 Mar 2024710.60k1.43%
Greenwoods Investments SG Pte Ltd.as of 31 Mar 2024348.86k0.70%
Barclays Bank Plc (Private Banking)as of 31 Mar 2024329.80k0.66%
Wellspring Financial Advisors LLCas of 31 Mar 2024180.17k0.36%
Renaissance Technologies LLCas of 31 Mar 2024114.39k0.23%
SSgA Funds Management, Inc.as of 31 Mar 202498.64k0.20%
Morgan Stanley & Co. LLCas of 31 Mar 202446.88k0.09%
Two Sigma Securities LLCas of 31 Mar 202435.97k0.07%
Citadel Securities LLCas of 31 Mar 202434.05k0.07%
Geode Capital Management LLCas of 31 Mar 202433.10k0.07%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.